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ABSTRACT 
Beta-Secretase is a transmembrane aspartic protease that cleaves the amyloid precursor 
protein (APP) to generate amyloid beta peptide (Aβ) that is believed to be responsible for 
the Alzheimer’s disease (AD). Beta-Secretaes include BACE1 and BACE2 which are close 
homologues, sharing 61.5% similarity and 45% identity at the amino acid level. BACE1 is 
responsible for generating amyloid plaques in Alzheimer’s disease through cleaving Aβ 
peptides from the amyloid precursor protein, however, the fragments of Aβ produced by 
BACE2-cleaved have not been observed in senile plaques in AD. The early onset of 
dementia in patients with Down’s syndrome is believed to be associated with BACE2, and 
it is believed to be greatly expressed in breast cancers. Although the structure of BACE1 
and BACE2 are very similar, there are some important different between their sequences 
and structure which made their function different with each other. In this study, I compared 
the conservation pattern of BACE1 and BACE2 throughout species and identified their 
active site by using evolutionary trace method. By using this method we can rank the 
functional significance of amino acids in the protein structure and also imply some data 
about the protein sequence-structure-function relationship. The result of this study 
identified that, in BACE1 and BACE2 structures, most of the conserved residues are 
located in the ligand binding site which are the key functionally residues for their activities. 
The other few conserved residues are more or less randomly localized in the rest of the 
structure. Also it was observed that, the structure of BACE1 and BACE2 reveals 
differences in some active site residues which may be of interest for the design of selective 
BACE1 or BACE2 inhibitors. 
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